UCLA Medical Center, Santa Monica

UCLA Health

Santa Monica, CA

Sorting 1 by

Accepting patients

iMMagine-3

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma
Learn more
  • CAR T Cell
  • BCMA
  • Randomization
  • Phase 3